Xspray Pharma AB (publ) (STO:XSPRAY)

Xspray Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	73.81	208.24	166.3	120.17	271.88	325.6
Cash & Short-Term Investments	73.81	208.24	166.3	120.17	271.88	325.6
Cash Growth	-41.69%	25.21%	38.39%	-55.80%	-16.50%	55.14%
Other Receivables	4.16	4.02	4.17	2.59	2.5	3.32
Receivables	4.16	4.02	4.17	2.59	2.5	3.32
Inventory	35.12	20.34	43.78	8.55	6.2	-
Prepaid Expenses	3.77	2.48	3.57	0.93	1.48	2.1
Other Current Assets	-0	0	-	-0	-0	-
Total Current Assets	116.85	235.07	217.82	132.23	282.07	331.02
Property, Plant & Equipment	75.07	79.18	107.65	64.6	44.6	42.67
Long-Term Investments	0	0	0	0	0	0
Long-Term Deferred Charges	501.83	478.93	436.78	385.6	296.24	231.62
Other Long-Term Assets	3.23	3.17	3.02	3	-	-
Total Assets	696.98	796.34	765.26	585.43	622.9	605.3
Accounts Payable	9.78	17.08	12.47	14.79	16.87	8.44
Accrued Expenses	16.42	18.63	16.31	11.41	10.3	8.54
Short-Term Debt	96	96	-	-	-	-
Current Portion of Leases	5.24	5.11	4.86	1.57	2.05	1.99
Other Current Liabilities	9.65	9.31	6.26	1.09	0.75	0.86
Total Current Liabilities	137.09	146.14	39.9	28.85	29.97	19.82
Long-Term Leases	24.44	27.11	31.95	0.56	1.19	2.9
Other Long-Term Liabilities	0	-0	-	-	-	-
Total Liabilities	161.53	173.25	71.85	29.41	31.15	22.72
Common Stock	37.14	37.14	31.25	22.68	20.68	18.89
Additional Paid-In Capital	1,425	1,425	1,216	907.42	813.48	709.41
Retained Earnings	-927.39	-840.25	-554.72	-374.08	-242.41	-145.71
Comprehensive Income & Other	0.66	1	0.79	-	-	-
Shareholders' Equity	535.45	623.1	693.41	556.02	591.75	582.59
Total Liabilities & Equity	696.98	796.34	765.26	585.43	622.9	605.3
Total Debt	125.68	128.22	36.81	2.13	3.23	4.88
Net Cash (Debt)	-51.87	80.02	129.5	118.04	268.65	320.72
Net Cash Growth	-	-38.21%	9.70%	-56.06%	-16.23%	56.80%
Net Cash Per Share	-1.45	2.41	4.87	5.60	13.96	18.63
Filing Date Shares Outstanding	37.14	37.14	31.25	22.68	20.68	18.89
Total Common Shares Outstanding	37.14	37.14	31.25	22.68	20.68	18.89
Working Capital	-20.24	88.93	177.91	103.38	252.1	311.2
Book Value Per Share	14.42	16.78	22.19	24.52	28.61	30.84
Tangible Book Value	535.45	623.1	693.41	556.02	591.75	582.59
Tangible Book Value Per Share	14.42	16.78	22.19	24.52	28.61	30.84
Machinery	-	51.5	52.12	49.82	46.96	39.87
Construction In Progress	-	41.39	59.37	46.57	20.04	15.75

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.